scholarly journals Psychoemotional status аnd quality of life of patients suffering from vertebrogenic pain syndromes

2019 ◽  
Vol 2019 (4) ◽  
pp. 44-47
Author(s):  
N.S. Kufterina ◽  
2015 ◽  
Vol 39 (3-4) ◽  
pp. 190-201 ◽  
Author(s):  
Rebecca A. Harrison ◽  
Thalia S. Field

Background: Pain is a common complication after stroke and is associated with the presence of depression, cognitive dysfunction, and impaired quality of life. It remains underdiagnosed and undertreated, despite evidence that effective treatment of pain may improve function and quality of life. Summary: We provide an overview of the means for clinical assessment and risk factors for the development of post-stroke pain, then review the newest available literature regarding the commonest post-stroke pain syndromes, including central post-stroke pain, complex regional pain syndrome, musculoskeletal pain including shoulder subluxation, spasticity-related pain, and post-stroke headache, as well as the available epidemiology and current treatment options. Key Messages: In the best interests of optimizing quality of life and function after stroke, clinicians should be aware of pain as a common complication after stroke, identify those patients at highest risk, directly inquire as to the presence and characteristics of pain, and should be aware of the options for treatment for the various pain syndromes.


1989 ◽  
Vol 18 (3) ◽  
pp. 271-282 ◽  
Author(s):  
Raymond C. Tait ◽  
Paul N. Duckro ◽  
Ronald B. Margolis ◽  
Richard Wiener

Using a combination of standardized and Likert-type measures of health, disability, and psychological adjustment, this study compared the quality of life reported by thirty-seven inpatients and thirty-six outpatients approximately eight months after completing treatment. While both patient groups reported treatment-related changes, inpatients were significantly more dysfunctional than outpatients both before and after treatment. The pattern of perceived improvement among inpatients reflected particular changes in narcotic use and in “up” time. For outpatients, the pattern of change pointed to increased periods of activity. The data are interpreted to reflect the need for treatments that are tailored to meet the differing levels of dysfunction of patients who present with chronic pain syndromes. Methodological problems of this and other clinical studies that compare treatment effects on patients demonstrating different levels of dysfunction are discussed.


2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 569-569
Author(s):  
Paul H. Cottu ◽  
Francoise Laroche ◽  
Jean-Yves Pierga ◽  
J Coste ◽  
T Medkour ◽  
...  

569 Background: Pain is frequent during Aromatase Inhibitors (AIs) treatment for breast cancer and several pain syndromes have been reported but not precisely defined. We developed a prospective multicentre study aiming at classifying AIs-related pain syndromes, comparing their impact on daily life, and identifying their specific determinants for a more targeted prevention approach. Methods: A one-year multicenter cohort prospective study, with 5 pre-scheduled visits, was carried out in early stage breast cancer women, free of pain, starting an AI treatment, recruited from 4 oncology centres. At baseline, clinical data (demography and psychosocial, cancer characteristics and treatments, pain, sleep, rheumatologic examination, cancer-related quality of life), biological data (sex hormones, vitamin D, bone biomarkers, oxidative stress, immunological and inflammatory markers), and genetic polymorphism for pain mechanisms (opioid and serotonin pathways) were recorded. Results: A cohort of 135 women was evaluated. Among them, 77 (57%) developed a pain syndrome along the study period, leading to AIs discontinuation in 12 cases. Five main different types of pain syndromes were identified: joint pain, in 48 women overall over the follow-up (36%), diffuse pain, in 30 women (22%), tendinitis, in 29 women (22%), and neuropathic pain, in 12 women (9%) and mixed types, which were frequent and often transient. Analyses demonstrated that risk factors for developing pain syndromes were baseline anxiety and impaired quality of life, while cancer features, genetic background, inflammation, immunological and sex hormone levels were not involved. Conclusions: In pain-free women with breast cancer starting an AI, risks for developing pain during the first year of treatment are slightly greater than 50%. We identified 5 main pain syndromes, joint and widespread pain being the most frequent. In all instances, initial psychological dimensions (personality, impaired quality of life and anxiety) are identified as major risk factors for pain development.


Author(s):  
G. Chuprуna ◽  
N. Svyrydova ◽  
N. Petrenko

We studied the prevalence of pain syndromes (РS) in patients with multiple sclerosis (MS) in order to clarify the characteristics of their occurrence and the extent of impact on quality of life, level of fatigue and depression in terms of comorbidity. The study involved 207 MS patients with different forms of course. Evaluated the clinical and demographic characteristics of the patients with MS due to comorbidity, conducted multidimensional assessment of pain using the McGill Pain Questionnaire, determines the level of EDSS, the severity of pain (VAS), the severity of fatigue (FSS), depression (BDI-II), quality of life (SF-36). The average prevalence of РS in all our study patients with MS was 76,3%. It was found that a РS in MS patients are more prevalent in patients with comorbid pathology.


Author(s):  
Geetha Desai ◽  
Santosh K. Chaturvedi ◽  
Dinesh Bhugra

Chronic pain and somatization are common reasons for consultation in health settings, including psychiatric services, in India. These are often manifestations of underlying psychiatric illnesses such as depression, anxiety, and other stress-related disorders. Assessment of chronic pain and somatization is essential because it may be a means for the patient to communicate psychological distress, arising out of stress and conflicts within the environment. Sociocultural factors have an important role in the manifestations, help-seeking, and management of these chronic pain and somatizing syndromes. Some specific pain syndromes and somatizing syndromes are seen in India, including that syndrome, sinking heart syndrome, and a variety of somatic neuroses. The management of pain and somatizing syndromes requires a multidisciplinary approach, with an aim to reduce distress and enhance quality of life, in an ethical way.


2021 ◽  
Vol 6 (2) ◽  

Background: Chronic scrotal content pain (CSCP) is a syndrome that seriously affects the quality of life in men. But in most men, there is no obvious structural abnormality and there may not be any identifiable pain on palpation, even medications and surgeries are not 100% effective and maybe cause other problems. In addition to medications and surgical treatment, any other effective method needs to be a therapeutic option, too. Objective: To discuss a 36-year-old patient with chronic scrotal content pain for 3 years, with a view to introduce a potentially effective treatment for Chronic scrotal content pain. Conclusions: Many pain syndromes can be treated with removal of the original stimulus. For the patients we treat, moxibustion is effective for the treatment of Chronic scrotal content pain caused by the cooling on the portion. Therefore, an effective conservative treatment may be a worthwhile option to try.


Sign in / Sign up

Export Citation Format

Share Document